Plasmapheresis for removal of myeloperoxidase antineutrophil cytoplasmic antibodies: a case report

Ther Apher. 1998 Nov;2(4):314-6. doi: 10.1111/j.1744-9987.1998.tb00131.x.

Abstract

We report on a patient with myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) associated glomerulonephritis who had an elevated MPO-ANCA level and necrotizing crescentic glomerulonephritis on renal biopsy. She was treated by double filtration plasmapheresis and immunoadsorption plasmapheresis combined with steroid therapy and immunosuppressive agents. After plasmapheresis, the MPO-ANCA level decreased, and the cellular crescents were reduced. We conclude that plasmapheresis combined with steroid and immunosuppressive therapy may be useful to decrease the activity of MPO-ANCA associated crescentic glomerulonephritis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Antineutrophil Cytoplasmic*
  • Female
  • Glomerulonephritis / immunology
  • Glomerulonephritis / therapy*
  • Glucocorticoids / therapeutic use
  • Humans
  • Plasmapheresis*
  • Prednisolone / therapeutic use

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Glucocorticoids
  • Prednisolone